These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28430350)

  • 1. 1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer.
    Cavaliere D; Cirocchi R; Coccolini F; Fagotti A; Fambrini M; Federici O; Lorusso D; Vaira M; Ceresoli M; Delrio P; Garofalo A; Pignata S; Scollo P; Trojano V; Amadori A; Ansaloni L; Cariti G; De Cian F; De Iaco P; De Simone M; Deraco M; Donini A; Fiorentini G; Frigerio L; Greggi S; Macrì A; Pasqual EM; Roviello F; Sammartino P; Sassaroli C; Scambia G; Staudacher C; Vici P; Vizza E; Valle M; ; ; ;
    Tumori; 2017 Nov; 103(6):525-536. PubMed ID: 28430350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies.
    Li Y; Zhou YF; Liang H; Wang HQ; Hao JH; Zhu ZG; Wan DS; Qin LX; Cui SZ; Ji JF; Xu HM; Wei SZ; Xu HB; Suo T; Yang SJ; Xie CH; Yang XJ; Yang GL
    World J Gastroenterol; 2016 Aug; 22(30):6906-16. PubMed ID: 27570426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
    Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia.
    Alzahrani N; Ferguson JS; Valle SJ; Liauw W; Chua T; Morris DL
    ANZ J Surg; 2016 Nov; 86(11):937-941. PubMed ID: 26179296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin.
    Kok NF; de Hingh IH
    Br J Surg; 2017 Mar; 104(4):313-315. PubMed ID: 28112791
    [No Abstract]   [Full Text] [Related]  

  • 7. Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    van Eden WJ; Kok NF; Jóźwiak K; Lahaye ML; Beets GL; van Leerdam ME; Boot H; Aalbers AG
    Dis Colon Rectum; 2017 May; 60(5):477-487. PubMed ID: 28383447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care.
    Sugarbaker PH
    Cancer Treat Rev; 2016 Jul; 48():42-9. PubMed ID: 27347669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastasis.
    Hall B; Padussis J; Foster JM
    Surg Clin North Am; 2017 Jun; 97(3):671-682. PubMed ID: 28501254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Kusamura S; Baratti D; Hutanu I; Gavazzi C; Morelli D; Iusco DR; Grassi A; Bonomi S; Virzì S; Haeusler E; Deraco M
    Eur J Surg Oncol; 2015 Aug; 41(8):1097-105. PubMed ID: 26026742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recurrent Peritoneal Metastases after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer].
    Königsrainer I; Struller F; Zieker D; Königsrainer A; Beckert S
    Zentralbl Chir; 2015 Dec; 140(6):607-9. PubMed ID: 23846542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperthermic intraperitoneal chemotherapy combined with cytoreductive procedure in patients with peritoneal pseudomyxoma].
    Gafton GI; Senchik KY; Kireeva GS; Petrov VG; Semiglazov VV; Guseynov KD; Bespalov VG; Belyaeva OA; Belyaev AM
    Khirurgiia (Mosk); 2016; (5):26-30. PubMed ID: 27271716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
    World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine second-look after surgical treatment of colonic peritoneal carcinomatosis.
    Delhorme JB; Triki E; Romain B; Meyer N; Rohr S; Brigand C
    J Visc Surg; 2015 Jun; 152(3):149-54. PubMed ID: 25650364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive cytoreductive surgery with hyperthermic intraperitoneal chemotherapy - a video vignette.
    Bullen TF; Fulford P; Wilson M; Aziz O; Renehan AG; O'Dwyer ST; Selvasekar CR
    Colorectal Dis; 2016 Nov; 18(11):1108. PubMed ID: 27649485
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Balaphas A; Belfontali V; Ris F; Lanitis A; Meier RP; Amram ML; Roth A; Huber O; Berney T; Morel P
    Rev Med Suisse; 2016 Jun; 12(523):1190-4. PubMed ID: 27487625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome.
    Macrì A; Maugeri I; Trimarchi G; Caminiti R; Saffioti MC; Incardona S; Sinardi A; Irato S; Altavilla G; Adamo V; Versaci A; Famulari C
    In Vivo; 2009; 23(1):147-50. PubMed ID: 19368140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytoreductive surgery and HIPEC for peritoneal malignancies in children].
    Seitz G; Fuchs J; Königsrainer I; Warmann SW; Königsrainer A; Beckert S
    Zentralbl Chir; 2014 Dec; 139(6):607-12. PubMed ID: 25531634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
    Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
    Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: an argued role.
    Di Giorgio A; Cardi M; Sammartino P
    Gynecol Oncol; 2010 Apr; 117(1):146-7. PubMed ID: 20096922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.